ALIPAGENE Trademark
Trademark Overview
On Friday, November 12, 1971, a trademark application was filed for ALIPAGENE with the United States Patent and Trademark Office. The USPTO has given the ALIPAGENE trademark a serial number of 72407526. The federal status of this trademark filing is EXPIRED as of Monday, May 16, 1994. This trademark is owned by INSTITUT PASTEUR. The ALIPAGENE trademark is filed in the Pharmaceutical Products category with the following description:
MEDICAMENTS AND PHARMACEUTICAL PRODUCTS-NAMELY; PREPARATIONS FOR INJECTION TO BE USED IN HUMAN THERAPY FOR THE DIAGNOSIS AND TREATMENT OF ALLERGIES
General Information
Serial Number | 72407526 |
Word Mark | ALIPAGENE |
Filing Date | Friday, November 12, 1971 |
Status | 900 - EXPIRED |
Status Date | Monday, May 16, 1994 |
Registration Number | 0965389 |
Registration Date | Tuesday, August 7, 1973 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | MEDICAMENTS AND PHARMACEUTICAL PRODUCTS-NAMELY; PREPARATIONS FOR INJECTION TO BE USED IN HUMAN THERAPY FOR THE DIAGNOSIS AND TREATMENT OF ALLERGIES |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 018 |
Class Status Code | 9 - Expired |
Class Status Date | Monday, May 16, 1994 |
Primary Code | 018 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | INSTITUT PASTEUR |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | PARIS XV FR |
Trademark Events
Event Date | Event Description |
Monday, May 16, 1994 | EXPIRED SEC. 9 |
Tuesday, November 20, 1979 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |